FormsNet3 - Blank Form


 
 
Sequence Number:    

 
 
Date Received: __ __ __ __ - __ __- __ __  

 
 
CIBMTR Center Number    

 
 
CIBMTR Recipient ID:    

 
 
Today's Date: __ __ __ __ - __ __- __ __  

 
 
Date of HSCT for which this form is being completed: __ __ __ __ - __ __- __ __  

 

HSCT Type (check all that apply): 

 
  

gfedcb
Autologous

 
 

  
gfedcb

Allogeneic, unrelated

 
 

  
gfedcb

Allogeneic, related

 
 

  
gfedcb

Syngeneic (identical twin)

 

Product Type (check all that apply): 

 
  

gfedcb
Marrow

 
 

  
gfedcb

PBSC

 
 

  
gfedcb

Cord blood

 
 

  
gfedcb

Other product

 
 
Specify:    

 
 

Visit:

  
 nmlkji

100 day  
 nmlkji

6 months  
 nmlkji

1 year  
 nmlkji

2 years  
 nmlkji

> 2 years,  

 
 
Specify:    

 
 

1  Was the Human Immunodeficiency Virus (HIV) infection diagnosed post-HSCT?

    
 nmlkji

yes  
 nmlkji

no  

 
 
2  Specify the date of diagnosis of HIV: __ __ __ __ - __ __- __ __  

 
 

3  Was antiviral therapy given for HIV since the date of the last report (or, if this is the first post-HSCT report, since diagnosis)?

    
 nmlkji

yes  
 nmlkji

no  

 

Abacavir (Ziagen) Therapy Given? 
 

4  Course given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
5  Date Started: __ __ __ __ - __ __- __ __  

 
 
6  Daily Dose:    mg 

 
 
7  Reason Anti-retroviral therapy started:   

 

Therapy paused for <1 week should not be considered as “Therapy Stopped”. 
 

8  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
9  Date Stopped: __ __ __ __ - __ __- __ __  

  Key Fields 

Antiviral Therapy for HIV Questions: 1 - 108

  Abacavir (Ziagen) Therapy (1) Questions: 4 - 9 

  Atazanavir (Reyataz) Therapy (1) Questions: 10 - 15 

Form 2148 R3.0: Human Immunodeficiency Virus Post-HSCT Data  
Center:  CRID: 

             CIBMTR Form 2148 revision 3.0 last updated January 2010
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 1 / 6



 

Atazanavir (Reyataz) Therapy Given? 
 

10  Course given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
11  Date Started: __ __ __ __ - __ __- __ __  

 
 
12  Daily Dose:    

mg 

 
 
13  Reason Anti-retroviral therapy started:   

 

Therapy paused for <1 week should not be considered as “Therapy Stopped”. 
 

14  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
15  Date Stopped: __ __ __ __ - __ __- __ __  

 

Didanosine (ddl, Videx, Videx EC) Therapy Given? 
 

16  Course given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
17  Date Started: __ __ __ __ - __ __- __ __  

 
 
18  Daily Dose:    mg 

 
 
19  Reason Anti-retroviral therapy started:   

 

Therapy paused for <1 week should not be considered as “Therapy Stopped”. 
 

20  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
21  Date Stopped: __ __ __ __ - __ __- __ __  

 

Efavirenz (Sustiva) Therapy Given? 
 

22  Course given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
23  Date Started: __ __ __ __ - __ __- __ __  

 
 
24  Daily Dose:    mg 

 
 
25  Reason Anti-retroviral therapy started:   

 

Therapy paused for <1 week should not be considered as “Therapy Stopped”. 
 

26  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
27  Date Stopped: __ __ __ __ - __ __- __ __  

 

Emtricitabine (Emtriva) Therapy Given? 
 

28  Course given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
29  Date Started: __ __ __ __ - __ __- __ __  

 
 
30  Daily Dose:    mg 

 
 
31  Reason Anti-retroviral therapy started:   

  Didanosine (ddl, Videx, Videx EC) Therapy (1) Questions: 16 - 21 

  Efavirenz (Sustiva)Therapy (1) Questions: 22 - 27 

  Emtricitabi (Emtriva) Therapy (1) Questions: 28 - 33 

Form 2148 R3.0: Human Immunodeficiency Virus Post-HSCT Data  
Center:  CRID: 

             CIBMTR Form 2148 revision 3.0 last updated January 2010
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 2 / 6



 

Therapy paused for <1 week should not be considered as “Therapy Stopped”. 
 

32  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
33  Date Stopped: __ __ __ __ - __ __- __ __  

 

Fosamprenavir (Lexiva) Therapy Given? 
 

34  Course given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
35  Date Started: __ __ __ __ - __ __- __ __  

 
 
36  Daily Dose:    

mg 

 
 
37  Reason Anti-retroviral therapy started:   

 

Therapy paused for <1 week should not be considered as “Therapy Stopped”. 
 

38  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
39  Date Stopped: __ __ __ __ - __ __- __ __  

 

Idinavir (Crixivan) Therapy Given? 
 

40  Course given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
41  Date Started: __ __ __ __ - __ __- __ __  

 
 
42  Daily Dose:    mg 

 
 
43  Reason Anti-retroviral therapy started:   

 

Therapy paused for <1 week should not be considered as “Therapy Stopped”. 
 

44  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
45  Date Stopped: __ __ __ __ - __ __- __ __  

 

Lamivudine (Epivir, Epzicom, 3TC) Therapy Given? 
 

46  Course given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
47  Date Started: __ __ __ __ - __ __- __ __  

 
 
48  Daily Dose:    mg 

 
 
49  Reason Anti-retroviral therapy started:   

 

Therapy paused for <1 week should not be considered as “Therapy Stopped”. 
 

50  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
51  Date Stopped: __ __ __ __ - __ __- __ __  

  Fosamprenav (Lexiva) Therapy (1) Questions: 34 - 39 

  Idinavir (Crixivan) Therapy (1) Questions: 40 - 45 

  Lamivudine (Epivir, Epzicom, 3TC) Therapy (1) Questions: 46 - 51 

  Lopinavir / Ritonavir (Kaletra) Therapy (1) Questions: 52 - 57 

Form 2148 R3.0: Human Immunodeficiency Virus Post-HSCT Data  
Center:  CRID: 

             CIBMTR Form 2148 revision 3.0 last updated January 2010
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 3 / 6



 

Lopinavir / Ritonavir (Kaletra) Therapy Given? 
 

52  Course given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
53  Date Started: __ __ __ __ - __ __- __ __  

 
 
54  Daily Dose:    mg 

 
 
55  Reason Anti-retroviral therapy started:   

 

Therapy paused for <1 week should not be considered as “Therapy Stopped”. 
 

56  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
57  Date Stopped: __ __ __ __ - __ __- __ __  

 

Nelfinavir (Viracept) Therapy Given? 
 

58  Course given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
59  Date Started: __ __ __ __ - __ __- __ __  

 
 
60  Daily Dose:    mg 

 
 
61  Reason Anti-retroviral therapy started:   

 

Therapy paused for <1 week should not be considered as “Therapy Stopped”. 
 

62  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
63  Date Stopped: __ __ __ __ - __ __- __ __  

 

Nevirapine (Viramune) Therapy Given? 
 

64  Course given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
65  Date Started: __ __ __ __ - __ __- __ __  

 
 
66  Daily Dose:    mg 

 
 
67  Reason Anti-retroviral therapy started:   

 

Therapy paused for <1 week should not be considered as “Therapy Stopped”. 
 

68  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
69  Date Stopped: __ __ __ __ - __ __- __ __  

 

Ritonavir (Norvir) Therapy Given? 
 

70  Course given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
71  Date Started: __ __ __ __ - __ __- __ __  

 
 
72  Daily Dose:    mg 

 
 
73  Reason Anti-retroviral therapy started:   

  Nelfinavir (Viracept) Therapy (1) Questions: 58 - 63 

  Nevirapine (Viramune) Therapy (1) Questions: 64 - 69 

  Ritonavir (Norvir) Therapy (1) Questions: 70 - 75 

Form 2148 R3.0: Human Immunodeficiency Virus Post-HSCT Data  
Center:  CRID: 

             CIBMTR Form 2148 revision 3.0 last updated January 2010
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 4 / 6



 

Therapy paused for <1 week should not be considered as “Therapy Stopped”. 
 

74  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
75  Date Stopped: __ __ __ __ - __ __- __ __  

 

Saquinavir (Fortovase, Invirase) Therapy Given? 
 

76  Course given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
77  Date Started: __ __ __ __ - __ __- __ __  

 
 
78  Daily Dose:    mg 

 
 
79  Reason Anti-retroviral therapy started:   

 

Therapy paused for <1 week should not be considered as “Therapy Stopped”. 
 

80  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
81  Date Stopped: __ __ __ __ - __ __- __ __  

 

Stavudine (Zerit, Zerti XR, d4t) Therapy Given? 
 

82  Course given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
83  Date Started: __ __ __ __ - __ __- __ __  

 
 
84  Daily Dose:    mg 

 
 
85  Reason Anti-retroviral therapy started:   

 

Therapy paused for <1 week should not be considered as “Therapy Stopped”. 
 

86  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
87  Date Stopped: __ __ __ __ - __ __- __ __  

 

Tenofovir (Truvada, Viread) Therapy Given? 
 

88  Course given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
89  Date Started: __ __ __ __ - __ __- __ __  

 
 
90  Daily Dose:    mg 

 
 
91  Reason Anti-retroviral therapy started:   

 

Therapy paused for <1 week should not be considered as “Therapy Stopped”. 
 

92  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
93  Date Stopped: __ __ __ __ - __ __- __ __  

  Saquinavir (Fortovase, Invirase) Therapy (1) Questions: 76 - 81 

  Stavudine (Zerit, Zerti XR, d4t) Therapy (1) Questions: 82 - 87 

  Tenofovir (Truvada, Viread) Therapy (1) Questions: 88 - 93 

  Zidovudine (Combivir, Retrovir, Trizivir, AZT) Therapy (1) Questions: 94 - 99 

Form 2148 R3.0: Human Immunodeficiency Virus Post-HSCT Data  
Center:  CRID: 

             CIBMTR Form 2148 revision 3.0 last updated January 2010
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 5 / 6



 

Zidovudine (Combivir, Retrovir, Trizivir, AZT) Therapy Given? 
 

94  Course given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
95  Date Started: __ __ __ __ - __ __- __ __  

 
 
96  Daily Dose:    mg 

 
 
97  Reason Anti-retroviral therapy started:   

 

Therapy paused for <1 week should not be considered as “Therapy Stopped”. 
 

98  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
99  Date Stopped: __ __ __ __ - __ __- __ __  

 

Other anti-retroviral therapy Therapy Given? 
 
100  Specify other antiviral therapy given:    

 
 

101  Course given:

    
 nmlkji

yes  
 nmlkji

no  

 
 
102  Date Started: __ __ __ __ - __ __- __ __  

 
 
103  Daily Dose:    mg 

 
 
104  Reason Anti-retroviral therapy started:   

 

Therapy paused for <1 week should not be considered as “Therapy Stopped”. 
 

105  Therapy Stopped?

    
 nmlkji

yes  
 nmlkji

no  

 
 
106  Date Stopped: __ __ __ __ - __ __- __ __  

 
 

107  For 100-day follow-up only: Was the recipient diagnosed with HIV prior to the HSCT?

    
 nmlkji

yes  
 nmlkji

no  

 
 

108  Did the recipient cease all anti-retroviral therapy from the start of the preparative regimen through the first 30 days post-HSCT?

    
 nmlkji

yes  
 nmlkji

no  

 

Provide all documented CD4 cell counts obtained since the date of the last report: 
 
109  Date: __ __ __ __ - __ __- __ __  

  
 
110  CD4 counts:    

 
Specify exponent: x10    

 

Provide all documented HIV viral load levels obtained since the date of the last report: 
 
111  Date: __ __ __ __ - __ __- __ __  

  
 
112  HIV viral load level:    

 
unit of measure

 nmlkji
copies/mL  

 nmlkji
log10/mL  

  
 
First Name:    

 
Last Name:    

  
 
Phone number:    

 
Fax number:    

 
 
E-mail address:    

  Other anti-retroviral therapy Therapy (1) Questions: 100 - 106 

  Serological Evidence of HIV Exposure / Infection Questions: 109 - 112

  CD4 Cell Counts (1) Questions: 109 - 110 

  HIV Viral Load Levels (1) Questions: 111 - 112 

Form 2148 R3.0: Human Immunodeficiency Virus Post-HSCT Data  
Center:  CRID: 

             CIBMTR Form 2148 revision 3.0 last updated January 2010
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 6 / 6